Related references
Note: Only part of the references are listed.Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2010)
IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
Jennifer Dien Bard et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Antiapoptotic Activity of Autocrine Mterleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts
Weici Zhang et al.
CLINICAL CANCER RESEARCH (2008)
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-Cell lymphoma with analysis of germinal center and post-germinal center biomarkers
Wyndham H. Wilson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma
J. Dien Bard et al.
LEUKEMIA (2008)
Structure of IL-22 bound to its high-affinity IL-22R1 chain
Brandi C. Jones et al.
STRUCTURE (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner
Lai Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage -: Case report
Frederik Neess Engsig et al.
APMIS (2007)
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1
Meili Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells
Lin Qiu et al.
BLOOD (2006)
Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors
Meili Zhang et al.
BLOOD (2006)
Jak3 contributes to the activation of ALK and Stat3 in ALK+ anaplastic large cell lymphoma
HM Amin et al.
LABORATORY INVESTIGATION (2006)
What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?
SD Turner et al.
LEUKEMIA (2005)
Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma
R Lai et al.
HUMAN PATHOLOGY (2005)
Neutrophil-rich anaplastic large cell lymphoma (NR-ALCL) mimicking lymphadenitis: A study by fine-needle aspiration biopsy
D Tamiolakis et al.
LEUKEMIA & LYMPHOMA (2004)
Genomic structure and inducible expression of the IL-22 receptor α chain in mice
A Tachiiri et al.
GENES AND IMMUNITY (2003)
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line - Pathways that are shared with and distinct from IL-10
D Lejeune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo et al.
ONCOGENE (2002)
Identification of the functional interleukin-22 (IL-22) receptor complex -: The IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes
SV Kotenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R
MH Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
HG Drexler et al.
LEUKEMIA (2000)
Share Paper
